Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Heart Failure - Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium
Immuron Ltd. - Immuron's BioGard HIV Antibody Into a U.S. Clinical Trial
Neuralgia - Solace Pharmaceuticals Initiates Phase IIa Trial of Glial Cell Modulator SLC022 in Post-Herpetic Neuralgia
Ovarian Cancer - First Patient Dosed in Phase 2 Clinical Trial of NKTR-102 in Ovarian Cancer
Addiction Medicine - Studies from University of Munich further understanding of addiction medicine
Alzheimer Disease - Research from H. Kessler and co-authors yields new data on Alzheimer disease
DNA Vaccines - New findings in DNA vaccines described from National Institutes of Health
Drug Resistance - New drug resistance findings from University of Salamanca described
Gene Therapy - Research from Leiden University in the area of gene therapy published
Glioblastoma - Research from University of California provides new data about glioblastoma
Glioma - Research conducted at University of California has provided new information about glioma
Melanoma - New melanoma study findings reported from M.B. Atkins and co-authors
Neuroblastoma - Data from H.V. Russell et al provide new insights into neuroblastoma
Non-Small Cell Lung Cancer - Findings from Indiana University broaden understanding of non-small cell lung cancer
Ovarian Cancer - New ovarian cancer research reported from U.A. Matulonis and co-authors
Breast Cancer Therapy - Report summarizes breast cancer therapy study findings from Vall d'Hebron University
Cancer Therapy - Research results from Brigham and Women's Cancer Center update knowledge of cancer therapy
Glycogen Storage Disease Gene Therapy - Researchers from Harvard University publish new studies and findings in the area of glycogen storage disease gene therapy
Ovarian Cancer Therapy - New ovarian cancer therapy research from Kinki University described
Pancreas - Researchers from Muenster University, Department of Medicine report on findings in pancreas
Prostate Cancer Therapy - Report summarizes prostate cancer therapy study findings from University of Toronto, Sunnybrook Health Science Center
Rectal Cancer Therapy - Reports from Vall d'Hebron University, Department of Radiation Oncology describe recent advances in rectal cancer therapy
Acceleron Pharma, Inc. - Acceleron Introduces Breakthrough Program for Treatment of Anemia at the 27th Annual JP Morgan Healthcare Conference
AcelRx Pharmaceuticals, Inc. - AcelRx Pharmaceuticals Reports Positive Results from a Clinical Trial of Sublingual Sufentanil/Triazolam NanoTab(TM) Combination (ARX-03) in Treating Procedural Pain and Anxiety
Analgesics - Cara Therapeutics Initiates Phase II Proof-Of-Concept Trial of Novel Analgesic in Acute Post-Operative Pain
BioLineRx Ltd. - BioLineRx Receives Approval to Complete Phase 1/2 Clinical Trials of BL-1040, a Breakthrough Treatment for Acute Myocardial Infarction
Bioscience - Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical Officer
Cancer - Champions Biotechnology and Concordia Pharmaceuticals Establish Royalty Agreement for Novel Oncology Drug
Clinical Trial Research - Anthera Completes Enrollment and Dosing of Varespladib Cardiovascular Trial
Clinical Trial Research - Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
Clinical Trial Research - MannKind Reports Successful Completion of Device Bioequivalence Trial
Clinical Trial Research - MAP Pharmaceuticals Provides Update on Progress of Two Phase 3 Clinical Programs
Colon Cancer - Poniard Pharmaceuticals Announces Positive Tumor Response and Neuropathy Data from Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
Crystal Research Associates, Llc - Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on BELLUS Health Inc.
Curis, Inc. - Curis Announces Genentech’s Expected Initiation of Pivotal Phase II Trial in Advanced Basal Cell Carcinoma with Hedgehog Pathway Inhibitor
Endocrine Research - New Study First to Confirm Sandostatin LAR(R) Depot Controls Tumor Growth in Patients With Rare Gastrointestinal Tumors
Fabry Disease - Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
Gastric Cancer - RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments
Genta Incorporated - Genta Initiates New Clinical Trial of Tesetaxel, the Leading Oral Taxane in Clinical Development
Genta Incorporated - Genta Updates Late-Stage Progress of Its Phase 3 Trial of Genasense® in Advanced Melanoma
Genzyme Corp. - Genzyme and Isis Begin New Clinical Trials of Mipomersen
Intra-Cellular Therapies, Inc. - Intra-Cellular Therapies Announces Successful Outcome of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia
Liver Cancer - Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer
Mystic Pharmaceuticals, Inc. - MacuCLEAR and Mystic Pharmaceuticals Agree To Collaborate on Macular Degeneration Phase I/II Clinical Trial
Neuralgia - NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by the Lancet Neurology
OBS Medical - Partnership Formed to Offer Next Generation Technologies and Services for Better Drug Cardiac Safety
Ovarian Cancer - Sunesis Pharmaceuticals Provides Year-End Clinical Update on Voreloxin
Parkinson Disease - Kyowa Hakko Kirin Announces Development Policy for Anti-Parkinson's Disease Drug KW-6002 (Istradefylline)
Parkinson Disease - Michael J. Fox Foundation Awards $2.9 Million for Two New Parkinson's Disease Clinical Trials
Pediatrics - Cephalon Signs Option Agreement to Acquire Ception Therapeutics
Tikcro Technologies Ltd. - USA FDA Allows BioCancell to Commence Phase I/IIa Ovarian and Pancreatic Clinical Trials
